506 related articles for article (PubMed ID: 34864675)
1. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
Crestini A; Santilli F; Martellucci S; Carbone E; Sorice M; Piscopo P; Mattei V
J Alzheimers Dis; 2022; 85(2):503-518. PubMed ID: 34864675
[TBL] [Abstract][Full Text] [Related]
2. Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease.
Kong C; Xie H; Gao Z; Shao M; Li H; Shi R; Cai L; Gao S; Sun T; Li C
Virol Sin; 2019 Oct; 34(5):475-488. PubMed ID: 31093882
[TBL] [Abstract][Full Text] [Related]
3. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
Carlson GA; Prusiner SB
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
[TBL] [Abstract][Full Text] [Related]
4. Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.
Brody AH; Strittmatter SM
Adv Pharmacol; 2018; 82():293-323. PubMed ID: 29413525
[TBL] [Abstract][Full Text] [Related]
5. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
6. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
7. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.
Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063
[TBL] [Abstract][Full Text] [Related]
8. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Marcilla I; Marti-Andres G; Caballero MC; Riverol M; Tuñon MT; Fraser PE; Luquin MR
Acta Neuropathol Commun; 2021 Apr; 9(1):64. PubMed ID: 33832546
[TBL] [Abstract][Full Text] [Related]
9. Oligomers of Amyloid β Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease.
Haas LT; Strittmatter SM
J Biol Chem; 2016 Aug; 291(33):17112-21. PubMed ID: 27325698
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
[TBL] [Abstract][Full Text] [Related]
11. Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease.
Ma WH; Chen AF; Xie XY; Huang YS
Neuropharmacology; 2021 Jun; 190():108342. PubMed ID: 33045243
[TBL] [Abstract][Full Text] [Related]
12. Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer's Disease Pathology.
Kawarabayashi T; Nakamura T; Sato K; Seino Y; Ichii S; Nakahata N; Takatama M; Westaway D; George-Hyslop PS; Shoji M
J Alzheimers Dis; 2022; 87(3):1189-1203. PubMed ID: 35431249
[TBL] [Abstract][Full Text] [Related]
13. Prion-like Mechanisms in Alzheimer's Disease.
Yin RH; Tan L; Jiang T; Yu JT
Curr Alzheimer Res; 2014; 11(8):755-64. PubMed ID: 25212914
[TBL] [Abstract][Full Text] [Related]
14. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
Viola KL; Klein WL
Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
[TBL] [Abstract][Full Text] [Related]
15. A New Bistable Switch Model of Alzheimer's Disease Pathogenesis.
Burlando B; Losacco S; Villa V; Fedele E; Ricciarelli R
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806088
[TBL] [Abstract][Full Text] [Related]
16. One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease.
Catania M; Di Fede G
Prog Mol Biol Transl Sci; 2020; 175():213-237. PubMed ID: 32958234
[TBL] [Abstract][Full Text] [Related]
17. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.
Um JW; Kaufman AC; Kostylev M; Heiss JK; Stagi M; Takahashi H; Kerrisk ME; Vortmeyer A; Wisniewski T; Koleske AJ; Gunther EC; Nygaard HB; Strittmatter SM
Neuron; 2013 Sep; 79(5):887-902. PubMed ID: 24012003
[TBL] [Abstract][Full Text] [Related]
18. The Prion-like Properties of Amyloid-beta Peptide and Tau: Is there Any Risk of Transmitting Alzheimer's Disease During Neurosurgical Interventions?
Padilla-Zambrano HS; García-Ballestas E; Quiñones-Ossa GA; Sibaja-Perez AE; Agrawal A; Moscote-Salazar LR; Menéndez-González M
Curr Alzheimer Res; 2020; 17(9):781-789. PubMed ID: 33280597
[TBL] [Abstract][Full Text] [Related]
19. Two mouse models of Alzheimer's disease accumulate amyloid at different rates and have distinct Aβ oligomer profiles unaltered by ablation of cellular prion protein.
Purro SA; Farmer M; Noble E; Sarell CJ; Powell M; Yip D; Giggins L; Zakka L; Thomas DX; Farrow M; Nicoll AJ; Walsh D; Collinge J
PLoS One; 2023; 18(11):e0294465. PubMed ID: 37976283
[TBL] [Abstract][Full Text] [Related]
20. Role of cellular prion protein in interneuronal amyloid transmission.
Del Río JA; Ferrer I; Gavín R
Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
